Concepedia

Author

Fumihiro Ishida

Shinshu UniversityORCID

Also Known As

Ayumi Fujimoto, F Ishida, F. Ishida, FUMIHIRO ISHIDA, FUMIO ISHIDA, Fumihiro ISHIDA, Fumihiro Ishida, Yukihiro Arai

184

Publications

4.5K

Citations

32

H-Index

102

Concepts

All Affiliations

Shinshu UniversityShinshu University HospitalNagoya UniversitySaitama Medical UniversityNagano Red Cross Hospital
FI

About

Fumihiro Ishida is an author at Shinshu University specializing in medicine, pathology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

39

1.8K

2

Health Sciences

9

9

251

3

Public Health

2

2

69

4

Natural Sciences

1

1

18

5

Allergy

1

1

18

Fumihiro Ishida

×

74

Publications

3.9K

Citations

29

H-Index

YearCitations

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Motoko Yamaguchi, Yok‐Lam Kwong, Won Seog Kim,

Journal of Clinical Oncology

2011

596

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard,

The Lancet Oncology

2016

375

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

Rika Kihara, Yasunobu Nagata, Hitoshi Kiyoi,

Leukemia

2014

228

Age-related Epstein-Barr virus (EBV)–associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients

Naoko Asano, Kazuhito Yamamoto, Jun‐ichi Tamaru,

Blood

2008

159

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada,

The Lancet Oncology

2018

152

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target

Olli Dufva, Matti Kankainen, Tiina Kelkka,

Nature Communications

2018

139

Clinicopathologic and Prognostic Significance of Cytotoxic Molecule Expression in Nodal Peripheral T-Cell Lymphoma, Unspecified

Naoko Asano, Ritsuro Suzuki, Yoshitoyo Kagami,

The American Journal of Surgical Pathology

2005

127

Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type

Yoshinori Ito, Hiroshi Kimura, Yoshinobu Maeda,

Clinical Cancer Research

2012

96

Regulation of Serum Thrombopoietin Levels by Platelets and Megakaryocytes in Patients with Aplastic Anaemia and Idiopathic Thrombocytopenic Purpura

Naoaki Ichikawa, Fumihiro Ishida, Shigetaka Shimodaira,

Thrombosis and Haemostasis

1996

94

Prognostic Significance of T-Cell or Cytotoxic Molecules Phenotype in Classical Hodgkin’s Lymphoma: A Clinicopathologic Study

Naoko Asano, Aya Oshiro, Keitaro Matsuo,

Journal of Clinical Oncology

2006

86

Page 1